Novartis AG - NVS (NYSE)

0.59 (0.71%)
Quotes delayed 15 mins. Currently August 20, 2018 4:01:57 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Novartis provides branded and generic medicines, diagnostic tools and consumer health products

Key Financials

Day Range:83.20 - 83.63
52 Week Range:72.30 - 94.19
Market Cap:194.17B
P/E Ratio:14.10
Div Yield:3.54
Previous close
No Chart Available
Purchase NVS in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of NVS not only as a single stock, but also as part of a motif.
Professional Motifs with NVS
Battling Cancer
Battling Cancer 31.0% 1 YR RTN New drugs and devices could be a game-changer for the war on the nation's second-biggest killer.
View all professional motifs with NVS
Community Motifs with NVS
Rising drug costs
Rising drug costs 16.6% 1 YR RTN
Big Pharma
Big Pharma 19.1% 1 YR RTN
Pharma/Drug PhRMAA
Pharma/Drug PhRMAA 8.7% 1 YR RTN
Pick 6- High Dividend
Pick 6- High Dividend 14.2% 1 YR RTN
View all community motifs with NVS
What Others Think About NVS
Marea Informative
Parnassus Investments CA Decreases Position in Novartis AG $NVS
Biotech Stocks To Watch As M&A's Heat Up The Sector… $TEVA $XBI $PFE $OPK $MRK $CVSI $GTBP $NOVN $CBPO $SILD $NVS
Do NOT expect to get anything useful from an INTERACT meeting (based on how they responded to pre-pre IND. If OTAT doesnt have time for two preINDs for me company (like thy granted $NVS for Kymriah), they better not waste time granting several IMPACT meetings for others!
Short sale volume(not short interest) for $ARRY on 2018-08-17 is 68%. $CELG 34% $AZN 26% $LLY 42% $NVS 37%
Beyond The Ninety Minutes
As Transocean $RIG Stock Price Rose, Shareholder Cambridge Investment Research Advisors Trimmed Stake by $379,512; As Novartis A G $NVS Market Value Declined, Godsey & Gibb Associates Has Increased by $332,800 Its Stake…
Related Companies Within The Drug Manufacturers - Major Sector
Pfizer Inc. - 42.41
AbbVie Inc. - 97.75